Characterization of two different cytoplasmic protein tyrosine kinases from human breast cancer

被引:8
|
作者
Chedin, M
Filhol, O
Duminy, C
Bolla, M
Benistant, C
Roche, S
Chambaz, EM
Cochet, C
机构
[1] CEA, DBMS,INSERM,U244, LAB BIOCHIM REGULAT CELLULAIRES ENDOCRINES, F-38054 GRENOBLE 9, FRANCE
[2] CHU GRENOBLE, UNITE CONCERTAT CANCEROL, F-38043 GRENOBLE 9, FRANCE
[3] FAC PHARM MONTPELLIER, CJF 9207, F-34033 MONTPELLIER, FRANCE
关键词
D O I
10.1093/carcin/18.8.1463
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Two different protein tyrosine kinases were detected in the cytosolic fraction of different human tumor tissues, After partial purification, the two enzymes, which were highly active in breast tumor tissues, were characterized, One of them, soluble tyrosine kinase-l (STK-1), represents a soluble form of the c-Src protein, which is apparently underphosphorylated on its C-terminal tyrosine residue whereas the other (STK-2) is a 48-kDa protein tyrosine kinase (PTK), which is molecularly and functionally related to the C-terminal Src kinase (Csk), These two protein tyrosine kinases clearly exhibit a different substrate specificity, and are responsible for the high tyrosine kinase activity present in the cytosolic fraction of human breast cancer, In addition, it was observed that STK-1 and STK-2 are also expressed in the breast cancer cell line, CAL-51.
引用
收藏
页码:1463 / 1472
页数:10
相关论文
共 50 条
  • [41] Characterization of Low Molecular Weight Protein Tyrosine Phosphatase Isoforms in Human Breast Cancer Epithelial Cell Lines
    Alho, Irina
    Costa, Luis
    Bicho, Manuel
    Coelho, Constanca
    ANTICANCER RESEARCH, 2013, 33 (05) : 1983 - 1987
  • [42] The ErbB/HER family of protein-tyrosine kinases and cancer
    Roskoski, Robert, Jr.
    PHARMACOLOGICAL RESEARCH, 2014, 79 : 34 - 74
  • [43] Inhibition of erbB receptor (HER) tyrosine kinases as a strategy to abrogate antiestrogen resistance in human breast cancer
    Kurokawa, L
    Arteaga, CL
    CLINICAL CANCER RESEARCH, 2001, 7 (12) : 4436S - 4442S
  • [44] Analysis of CD28 cytoplasmic tail tyrosine residues as regulators and substrates for the protein tyrosine kinases, EMT and LCK
    King, PD
    Sadra, A
    Teng, JMC
    Liu, XR
    Han, A
    Selvakumar, A
    August, A
    Dupont, B
    JOURNAL OF IMMUNOLOGY, 1997, 158 (02): : 580 - 590
  • [45] Interaction of estrogen receptor and receptor-tyrosine kinases in human breast cancer cell lines.
    Treeck, O
    Porz, S
    Eggert, K
    Diedrich, K
    Ortmann, O
    BREAST CANCER RESEARCH AND TREATMENT, 2001, 69 (03) : 273 - 273
  • [46] ISOLATION AND PARTIAL CHARACTERIZATION OF DISTINCT FORMS OF TYROSINE PROTEIN-KINASES FROM RAT SPLEEN
    BRUNATI, AM
    MARCHIORI, F
    PINNA, LA
    FEBS LETTERS, 1985, 188 (02) : 321 - 325
  • [47] Two different pathways link G-protein-coupled receptors with tyrosine kinases for the modulation of growth and survival in human hematopoietic progenitor cells
    Vichalkovski, A
    Baltensperger, K
    Thomann, D
    Porzig, H
    CELLULAR SIGNALLING, 2005, 17 (04) : 447 - 459
  • [48] CHARACTERIZATION OF 4 TYROSINE PROTEIN-KINASES FROM THE PARTICULATE-FRACTION OF RAT SPLEEN
    BRUNATI, AM
    PINNA, LA
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 1988, 172 (02): : 451 - 457
  • [49] Type I Receptor Tyrosine Kinases as Targets for Therapy in Breast Cancer
    José Baselga
    John Mendelsohn
    Journal of Mammary Gland Biology and Neoplasia, 1997, 2 : 165 - 174
  • [50] SEARCHING FOR RECEPTOR TYROSINE KINASES AS MOLECULAR TARGETS IN BREAST CANCER TREATMENT
    Roussidis, A. E.
    Theocharis, A. D.
    Karamanos, N. K.
    ANTICANCER RESEARCH, 2004, 24 (5D) : 3615 - 3615